Clinical Trial Update: LGG for Prevention of Infectious Complications During PPI Treatment in Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the probiotic Lactobacillus rhamnosus GG (LGG) to prevent infectious complications in children on proton pump inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Gastrointestinal Infections
• Respiratory Tract Infections

Drugs mentioned

• Lactobacillus rhamnosus GG (LGG) (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Gastroesophageal Reflux Disease, Gastrointestinal Infections | Phase 4 | Status: UNKNOWN